Prof. Dr. med. Thomas Gottwald is Member of the Supervisory Board and major shareholder of the Ovesco Endoscopy AG, a company developing, producing and marketing cutting edge medical devices for endoscopy.

From 2009 until 2021 he was sharing the CEO position with the current CEO. Prior to these engagements Thomas Gottwald held a number of management positions at Fresenius SE where he was founding President and CEO of Fresenius Biotech GmbH, and also served as worldwide Medical Director and Managing Director of Fresenius HemoCare GmbH, as well as Global Medical Director at Fresenius Kabi AG and Managing Director of Fresenius Kabi Deutschland GmbH.

He is a general and visceral surgeon by training with close to twenty years of clinical experience and scientific expertise. In addition to his current business angel, consulting and advisory activities for various companies at home and abroad (like Atmos GmbH, ICA InContAlert, HSP Kera GmbH, Ascenion GmbH and others), he continues his scientific work and teaching activities as an associate professor of surgery and member of the Medical Faculty of Tübingen University.